Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Nancy McKinney who wrote (5638)	9/23/1998 5:26:00 PM
From: Dauntless	Read Replies (1) \| Respond to of 7041

Nancy & thread - more lies from Dauntless? In an interview today, Schering-Plough..... ===================================================== Chief Executive Richard Kogan said Wednesday...... .... He said the earnings outlook was also brightened by Vasomax, an anti-impotence pill that Schering-Plough will market for Zonagen Inc. (Nasdaq:ZONA - news). Previously, analysts have said Vasomax is less effective than Pfizer Inc's (NYSE:PFE - news) blockbuster anti-impotence pill Viagra launched earlier this year, but could achieve decent sales, in part, because of possibly milder side effects for patients with cardiovascular problems. ================================================= Here's the link to the entire interview biz.yahoo.com I guess this guy is in cahoots with Joe? I dunno, maybe it's just me, but it seems like a guy in his position would be REAL CAREFUL about what he said - he wouldn't want to be called a "filthy crook".